Cargando…

Validation of the cell cycle progression score to differentiate indolent from aggressive prostate cancer in men diagnosed through transurethral resection of the prostate biopsy

BACKGROUND: Validation of biomarker‐based prognostic models to improve risk stratification in men with localized prostate cancer (PrCa) remains a clinical need. It has previously been shown that the cell cycle progression (CCP) test provides significant, independent prognostic information for men wh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cuzick, Jack M., Stone, Steven, Lenz, Lauren, Flake, Darl D., Rajamani, Saradha, Moller, Henrik, Berney, Daniel Maurice, Cohen, Todd, Scardino, Peter T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351676/ https://www.ncbi.nlm.nih.gov/pubmed/34423592 http://dx.doi.org/10.1002/cnr2.1535

Ejemplares similares

The percentage of high‐grade prostatic adenocarcinoma in prostate biopsies significantly improves on Grade Groups in the prediction of prostate cancer death
por: Berney, Daniel M, et al.
Publicado: (2019)

Should reporting of peri-neural invasion and extra prostatic extension be mandatory in prostate cancer biopsies? correlation with outcome in biopsy cases treated conservatively
por: Ahmad, Amar S., et al.
Publicado: (2018)

Validation of a contemporary prostate cancer grading system using prostate cancer death as outcome
por: Berney, Daniel M, et al.
Publicado: (2016)

Prognostic value of Ki-67 for prostate cancer death in a conservatively managed cohort
por: Fisher, G, et al.
Publicado: (2013)

Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort
por: Cuzick, J, et al.
Publicado: (2012)

Validation of an RNA cell cycle progression score for predicting death from prostate cancer in a conservatively managed needle biopsy cohort
por: Cuzick, J, et al.
Publicado: (2015)

Ki-67 and outcome in clinically localised prostate cancer: analysis of conservatively treated prostate cancer patients from the Trans-Atlantic Prostate Group study
por: Berney, D M, et al.
Publicado: (2009)

Long-term outcome among men with conservatively treated localised prostate cancer
por: Cuzick, J, et al.
Publicado: (2006)

Transurethral balloon dilatation of the Prostate and Transurethral Plasmakinetic resection of the Prostate in the treatment of Prostatic Hyperplasia
por: Chang, Yanhua, et al.
Publicado: (2018)

Prognostic value of PTEN loss in men with conservatively managed localised prostate cancer
por: Cuzick, J, et al.
Publicado: (2013)

Safety and Efficacy of Combined Transrectal Ultrasound-Guided Prostate Needle Biopsy and Transurethral Resection of the Prostate
por: Cho, Jeong Man, et al.
Publicado: (2010)

Comparison between thulium laser resection of prostate and transurethral plasmakinetic resection of prostate or transurethral resection of prostate
por: DeCao, Hong, et al.
Publicado: (2015)

Nonspecific Presentation of a Multiloculated Prostatic Abscess After Transurethral Prostatic Biopsy for Elevated Prostate-specific Antigen Level
por: Gandhi, Nilay M., et al.
Publicado: (2014)

DNA methylation gene-based models indicating independent poor outcome in prostate cancer
por: Vasiljević, Nataša, et al.
Publicado: (2014)

A novel DNA methylation score accurately predicts death from prostate cancer in men with low to intermediate clinical risk factors
por: Ahmad, Amar S., et al.
Publicado: (2016)

Transurethral Resection of Prostate Abscess: Is It Different from Conventional Transurethral Resection for Benign Prostatic Hyperplasia?
por: Goyal, Neeraj Kumar, et al.
Publicado: (2013)

Mir143 expression inversely correlates with nuclear ERK5 immunoreactivity in clinical prostate cancer
por: Ahmad, I, et al.
Publicado: (2013)

Automated detection of aggressive and indolent prostate cancer on magnetic resonance imaging
por: Seetharaman, Arun, et al.
Publicado: (2021)

AB016. Transurethral PlasmaKinetic enucleation of prostate versus transurethral PlasmaKinetic resection of prostate for benign prostate hyperplasia
por: Sun, Ting, et al.
Publicado: (2016)

Prevalence and risk factors for incidental prostate cancer in patients after transurethral resection of the prostate with negative results on prostate biopsy: A retrospective study
por: Guo, Zhenlang, et al.
Publicado: (2022)

Focal amplification of the androgen receptor gene in hormone-naive human prostate cancer
por: Merson, S, et al.
Publicado: (2014)

Transurethral resection of the prostate stricture management
por: Wang, Jian-Wei, et al.
Publicado: (2019)

Safety of transurethral resection of large prostate
por: Al-Bakri, Ayman, et al.
Publicado: (2023)

Mapping the Germline and Somatic Mutation Interaction Landscape in Indolent and Aggressive Prostate Cancers
por: Mamidi, Tarun Karthik Kumar, et al.
Publicado: (2019)

Hsp-27 expression at diagnosis predicts poor clinical outcome in prostate cancer independent of ETS-gene rearrangement
por: Foster, C S, et al.
Publicado: (2009)

Comparison between a transurethral prostate split and transurethral prostate resection for benign prostatic hyperplasia treatment in a small prostate volume: a prospective controlled study
por: Wang, Bohan, et al.
Publicado: (2020)

Endothelin-1 Expression in Prostate Needle Biopsy Specimens Correlated With Aggressiveness of Prostatic Cancer
por: Asgari, Mojgan, et al.
Publicado: (2017)

Identification of FBXL4 as a Metastasis Associated Gene in Prostate Cancer
por: Stankiewicz, Elzbieta, et al.
Publicado: (2017)

Prostatic artery embolization versus transurethral resection of the prostate in management of benign prostatic hyperplasia
por: Radwan, Ahmed, et al.
Publicado: (2020)

Comparison of plasmakinetic transurethral resection of the prostate with monopolar transurethral resection of the prostate in terms of urethral stricture rates in patients with comorbidities
por: Sinanoglu, Orhun, et al.
Publicado: (2014)

Incidental Prostate Cancer in Transurethral Resection of the Prostate Specimens in the Modern Era
por: Otto, Brandon, et al.
Publicado: (2014)

The role of transurethral resection of the prostate for patients with an elevated prostate-specific antigen
por: Cho, Hee Ju, et al.
Publicado: (2014)

Does asymptomatic prostatic inflammation alter the outcome of transurethral resection of prostate?
por: Dangi, Anuj Deep, et al.
Publicado: (2017)

The impact of prostate-transurethral resection on erectile dysfunction in benign prostatic hyperplasia
por: Oka, Anak Agung Gde, et al.
Publicado: (2019)

Risk Factors for Prostate Volume Progression After Prostate-Transurethral Resection
por: Duarsa, Gede Wirya Kusuma, et al.
Publicado: (2020)

Transurethral Drainage of Prostatic Abscess: Points of Technique
por: El-Shazly, Mohamed, et al.
Publicado: (2012)

An update on transurethral surgery for benign prostatic obstruction
por: Teo, Jonathan Shunming, et al.
Publicado: (2017)

Rectourethral Fistula Secondary to Transurethral Resection of the Prostate
por: Gayam, Vijay, et al.
Publicado: (2018)

Can bipolar transurethral enucleation of the prostate be a better alternative to the bipolar transurethral resection of the prostate?: A prospective comparative study
por: Abdulwahab Al-radhi, Mohammed, et al.
Publicado: (2021)

Prostate stromal tumor with prostatic cysts after transurethral resection of the prostate: A case report
por: Zhao, Li-Wei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_brrhifpeo6fjdjk8r6oikt6ks6